MMT Hospital
  • KARAZANASHVILI ROBOTIC CENTER
(+995) 322 23 40 23
No Result
View All Result
  • Home
  • About Us
    • Hospital
    • Doctors
    • Medical Equipment
    • Administration
    • Quality Control
  • News
  • Services
    • Urological Hub
    • Gynaecological Hub
    • Oncology
    • Surgery
  • For Patients
    • Manager
    • Symptoms
    • Deseases
    • Medical Examinations
    • Treatment Methods
    • Insurance
    • Healthcare Programs
    • Online Consultation
    • Book an Appointment
  • For Doctors
    • Guidelines
    • Scientific Studies
  • Patient stories
  • Contact information
  • Book an Appointment
  • GE
  • RU
  • Home
  • About Us
    • Hospital
    • Doctors
    • Medical Equipment
    • Administration
    • Quality Control
  • News
  • Services
    • Urological Hub
    • Gynaecological Hub
    • Oncology
    • Surgery
  • For Patients
    • Manager
    • Symptoms
    • Deseases
    • Medical Examinations
    • Treatment Methods
    • Insurance
    • Healthcare Programs
    • Online Consultation
    • Book an Appointment
  • For Doctors
    • Guidelines
    • Scientific Studies
  • Patient stories
  • Contact information
  • Book an Appointment
MMT ჰოსპიტალი
No Result
View All Result
Home News

Hormone Therapy for Prostate Cancer

10/02/2025
in News, Oncology
Гормональная терапия при раке простаты
Share on FacebookShare on Twitter
This article is available in: Русский & ქართული

Prostate cancer most commonly develops in men over 50 years old and is a relatively slow-growing cancer, making it the most common cancer in men.

Hormone therapy is considered the gold standard for treating advanced prostate cancer.

Prostate cancer is most often an adenocarcinoma (glandular cancer) based on its tissue structure. Prostate tissue grows under the influence of male hormones, called androgens, and is therefore classified as a hormone-dependent cancer.

It always contains hormone-resistant cells (which continue to survive even after castration). After castration, all prostate cancers eventually become hormone-resistant. The cancer becomes hormone-refractory, meaning it no longer responds to hormone therapy and continues to grow despite castration.

Hormone therapy itself involves blocking the “feeding” testosterone in the body to make the cancer cells stop growing. This can be achieved through medication (estrogens, LH-RH analogs) or surgical castration (orchiectomy).

As mentioned above, hormone therapy aims to remove as many androgens from the male body as possible. The primary source of androgens in the male body is the testes.

However, androgens are also produced in the adrenal glands in men.

To neutralize their effect on prostate tissue, anti-androgens are additionally used. These block the stimulating effect of androgens on prostate cancer cells.

This combination (hormone therapy + anti-androgens) is called maximum androgen blockade.

Gonadotropin-releasing hormone (GnRH) agonists include: Goserelin, Leuprolide, Decapeptil, Differil, etc. These medications are available in 1-month and 3-month doses. After the first injection, the initial days may see increased testosterone metabolism, which could lead to increased pain in metastatic areas and urinary retention. To prevent this, LH-RH analog treatment should be preceded by 5-7 days of anti-androgen therapy.

Hormone therapy has a number of side effects, including: lipid metabolism disturbances, myocardial infarction, stroke, high risk of developing diabetes, and osteoporosis (the complication of which is pathological fractures).

MMT Hospital offers patients the full course of hormone therapy and chemotherapy for any pathology.

 

ShareTweetSendShareSend
Previous Post

Trust your health only to professionals! – Bladder cancer treatment at the “Karazanashvili Robotic Center”

Next Post

Prostate cancer – from early detection to early stage prostate cancer management

პროფესორი გურამ ქარაზანაშვილი ევროპის უროლოგთა ასოციაციის (EAU) მე-40 ყოველწლიურ კონგრესზე (EAU25)
News

Professor Guram Karazanashvili at the 40th Annual Congress of the European Association of Urology (EAU25)

ქალებში შარდის შეუკავებლობა, როგორია პრობლემის მოგვარების მეთოდი რობოტული ოპერაციით?
Gynaecological Hub

Urinary Incontinence in Women – Treatment with Robotic Surgery

მორიგი კონფერენცია საქართველოსა და კავკასიის მასშტაბით “პროსტატის კიბოს თანამედროვე მართვა”
News

Conference on “Modern Management of Prostate Cancer”

მორიგი კონფერენცია საქართველოსა და კავკასიის მასშტაბით “პროსტატის კიბოს თანამედროვე მართვა”
News

Another conference across Georgia and the Caucasus on “Modern Management of Prostate Cancer”

No Result
View All Result

NEWS

პროფესორი გურამ ქარაზანაშვილი ევროპის უროლოგთა ასოციაციის (EAU) მე-40 ყოველწლიურ კონგრესზე (EAU25)
НОВОСТИ

Профессор Гурам Каразанашвили на 40-м Ежегодном Конгрессе Европейской Ассоциации Урологов (EAU25)

ქალებში შარდის შეუკავებლობა, როგორია პრობლემის მოგვარების მეთოდი რობოტული ოპერაციით?
ГИНЕКОЛОГИЧЕСКИЙ ЦЕНТР

Недержание мочи у женщин – лечение с помощью роботизированной хирургии

მორიგი კონფერენცია საქართველოსა და კავკასიის მასშტაბით “პროსტატის კიბოს თანამედროვე მართვა”
НОВОСТИ

Конференция на тему “Современное управление раком простаты”

მორიგი კონფერენცია საქართველოსა და კავკასიის მასშტაბით “პროსტატის კიბოს თანამედროვე მართვა”
НОВОСТИ

Очередная конференция в масштабе Грузии и Кавказа на тему “Современное управление раком простаты”

უროლოგიური კვლევები
НОВОСТИ

Урологические исследования

გურამ ქარაზანაშვილი რობოტული ქირურგიის დამფუძნებელი საქართველოსა და კავკასიაში
НОВОСТИ

Гурам Каразанашвили – основатель роботической хирургии в Грузии и на Кавказе

2025 © KRC

  • Home
  • About Us
    • Hospital
    • Doctors
    • Medical Equipment
    • Administration
    • Quality Control
  • News
  • Services
    • Urological Hub
    • Gynaecological Hub
    • Oncology
    • Surgery
  • For Patients
    • Manager
    • Symptoms
    • Deseases
    • Medical Examinations
    • Treatment Methods
    • Insurance
    • Healthcare Programs
    • Online Consultation
    • Book an Appointment
  • For Doctors
    • Guidelines
    • Scientific Studies
  • Patient stories
  • Contact information
  • Book an Appointment
No Result
View All Result
  • GE
  • RU

2025 © KRC